AstraZeneca PLC Meet the Management: Weight Management Virtual Event Transcript - Thomson StreetEvents

AstraZeneca PLC Meet the Management: Weight Management Virtual Event Transcript

AstraZeneca PLC Meet the Management: Weight Management Virtual Event Transcript - Thomson StreetEvents
AstraZeneca PLC Meet the Management: Weight Management Virtual Event Transcript
Published Nov 04, 2024
20 pages (13420 words) — Published Nov 04, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of AZN.L corporate analyst meeting

  
Brief Excerpt:

...Operator Good morning to those joining from the US, good afternoon to those in the UK and Central Europe, and good evening to those listening in Asia. Welcome, ladies and gentlemen, to the AZN Meet the Management Webinar, CVRM Weight Management for Investors and Analysts. Before I hand it over to veto AstraZeneca, I'd like to read the Safe Harbor statement. The company intends to utilize the Safe Harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca. Although we believe our expectations are based on stable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements made on this call reflect the knowledge...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
AstraZeneca PLC
Ticker
AZN.L
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: James Gordon - JPMorgan - Analyst : James Gordon from JPMorgan. Two quick questions, please. What was the old GLP-1? I didn't quite get, but was this assessing that there was any liver Was that what the -- one of the grade events was? And so can you clarify how many cases of liver toxin and what grade it was or I said liver talks liver enzyme elevations. The other question was the long-acting amylin which looked interesting. And I know there's been quite a bit of excitement in some other long-acting amylin, but (inaudible) I think is probably the most mature we've seen -- and I think the pitch there was better tolerability than drugs like bound with similar weight loss. But in terms of how you think 234 could be differentiated versus Petri, is the idea that because you hit less, you could be even cleaner? Or is it some other aspect like body composition, how do you think it will be different because I think it binds a bit differently?

Table Of Contents

AstraZeneca PLC Q1 2025 Earnings Call Transcript – 2025-04-29 – US$ 106.00 – Edited Transcript of AZN.L earnings conference call or presentation 29-Apr-25 10:45am GMT

AstraZeneca PLC Q4 2024 Earnings Call Transcript – 2025-02-06 – US$ 54.00 – Edited Transcript of AZN.L earnings conference call or presentation 6-Feb-25 11:00am GMT

AstraZeneca PLC at JPMorgan Healthcare Conference Transcript – 2025-01-14 – US$ 54.00 – Edited Transcript of AZN.L presentation 14-Jan-25 5:00pm GMT

AstraZeneca PLC Health Equity Investor Event Transcript – 2024-11-15 – US$ 54.00 – Edited Transcript of AZN.L corporate analyst meeting</ 15-Nov-24 1:00pm GMT

AstraZeneca PLC Q3 2024 Earnings Call Transcript – 2024-11-12 – US$ 54.00 – Edited Transcript of AZN.L earnings conference call or presentation 12-Nov-24 2:00pm GMT

AstraZeneca PLC at OTC Deutsche Bank ADR Investor Conference (Virtual) Transcript – 2024-09-24 – US$ 54.00 – Edited Transcript of AZN.L presentation 24-Sep-24 3:30pm GMT

AstraZeneca PLC Meet the Management at ESMO 2024 Transcript – 2024-09-16 – US$ 54.00 – Edited Transcript of AZN.L corporate analyst meeting</ 16-Sep-24 6:00pm GMT

AstraZeneca PLC Meet the Management: Lung Cancer and QCS Presentation Transcript – 2024-09-09 – US$ 54.00 – Edited Transcript of AZN.L conference call or presentation 9-Sep-24 8:00pm GMT

AstraZeneca PLC ASCO Meet the Management Transcript – 2024-06-04 – US$ 54.00 – Edited Transcript of AZN.L corporate analyst meeting</ 4-Jun-24 12:30am GMT

AstraZeneca PLC Sustainability 2023 Highlights Summary Call Transcript – 2024-03-22 – US$ 54.00 – Edited Transcript of AZN.L conference call or presentation 22-Mar-24 2:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "AstraZeneca PLC Meet the Management: Weight Management Virtual Event Transcript" Nov 04, 2024. Alacra Store. May 06, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/AstraZeneca-PLC-Meet-the-Management-Weight-Management-Virtual-Event-T16168271>
  
APA:
Thomson StreetEvents. (2024). AstraZeneca PLC Meet the Management: Weight Management Virtual Event Transcript Nov 04, 2024. New York, NY: Alacra Store. Retrieved May 06, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/AstraZeneca-PLC-Meet-the-Management-Weight-Management-Virtual-Event-T16168271>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.